MTOR and pulmonary emphysema: Similarly, inhibition of the mTOR pathway with the AMP-activated protein kinase (AMPK) activator metformin was shown to decrease the development of senescence, SASP secretion, and emphysema in the elastase-induced murine model of emphysema (Cheng et al., 2017).